{
    "status": "accepted",
    "chain_of_thought": "[Article Type: Case Report] In this article, I found the following liver injury-related lab values and clinical outcomes: The patient is a 62-year-old male with HIV who developed liver enzyme elevations after long-term efavirenz therapy. The case presentation section provides specific lab values from May 2022 showing ALT 167 IU/L, AST 154 IU/L, GGT 147 IU/L, ALP 178 IU/L, with bilirubin, albumin, and INR reported as normal. Table 1 confirms these peak values and shows normalization after efavirenz withdrawal. The clinical outcome is clearly described as improvement with normalization of liver enzymes and other parameters after drug discontinuation, with the patient remaining clinically well.",
    "patient_age": "62",
    "patient_gender": "Male",
    "suspected_drug": "Efavirenz",
    "lab_results": {
        "ALT": "167 IU/L",
        "AST": "154 IU/L",
        "ALP": "178 IU/L",
        "GGT": "147 IU/L",
        "Bilirubin": "Normal (8 Âµmol/L total bilirubin)",
        "INR": "Normal (1.1)",
        "Albumin": "Normal (43 g/L)"
    },
    "clinical_outcome": "Improved/Discharged",
    "AI_confidence_score": 0.95
}